Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?
- PMID: 18056479
- PMCID: PMC2258851
- DOI: 10.1128/IAI.00431-07
Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?
Similar articles
-
The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.Int J Parasitol. 2012 Aug;42(9):859-70. doi: 10.1016/j.ijpara.2012.07.001. Epub 2012 Jul 28. Int J Parasitol. 2012. PMID: 22846785
-
Immunogenicity and structural efficacy of P41 of Plasmodium sp. as potential cross-species blood-stage malaria vaccine.Comput Biol Chem. 2021 Jun;92:107493. doi: 10.1016/j.compbiolchem.2021.107493. Epub 2021 Apr 24. Comput Biol Chem. 2021. PMID: 33962170
-
Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.Infect Immun. 2017 Jun 20;85(7):e00062-17. doi: 10.1128/IAI.00062-17. Print 2017 Jul. Infect Immun. 2017. PMID: 28438976 Free PMC article. Review.
-
Chimeric parasites as tools to study Plasmodium immunology and assess malaria vaccines.Methods Mol Biol. 2013;923:465-79. doi: 10.1007/978-1-62703-026-7_32. Methods Mol Biol. 2013. PMID: 22990798 Review.
-
Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites.J Infect Dis. 2009 Mar 15;199(6):899-903. doi: 10.1086/597121. J Infect Dis. 2009. PMID: 19434915
Cited by
-
Studies on Immunogenicity and Antigenicity of Baculovirus-Expressed Binding Region of Plasmodium falciparum EBA-140 Merozoite Ligand.Arch Immunol Ther Exp (Warsz). 2016 Apr;64(2):149-56. doi: 10.1007/s00005-015-0367-5. Epub 2015 Oct 6. Arch Immunol Ther Exp (Warsz). 2016. PMID: 26439848 Free PMC article.
-
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.J Infect Dis. 2013 Feb 15;207(4):656-60. doi: 10.1093/infdis/jis725. Epub 2012 Nov 27. J Infect Dis. 2013. PMID: 23186785 Free PMC article. Clinical Trial.
-
Cross-species analysis of apical asparagine-rich protein of Plasmodium vivax and Plasmodium knowlesi.Sci Rep. 2018 Apr 10;8(1):5781. doi: 10.1038/s41598-018-23728-1. Sci Rep. 2018. PMID: 29636493 Free PMC article.
-
In vivo CD8+ T cell dynamics in the liver of Plasmodium yoelii immunized and infected mice.PLoS One. 2013 Aug 14;8(8):e70842. doi: 10.1371/journal.pone.0070842. eCollection 2013. PLoS One. 2013. PMID: 23967119 Free PMC article.
-
Babesia microti alleviates disease manifestations caused by Plasmodium berghei ANKA in murine co-infection model of complicated malaria.Front Cell Infect Microbiol. 2023 Jul 10;13:1226088. doi: 10.3389/fcimb.2023.1226088. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37492527 Free PMC article.
References
-
- Amino, R., S. Thiberge, B. Martin, S. Celli, S. Shorte, F. Frischknecht, and R. Ménard. 2006. Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat. Med. 12220-224. - PubMed
-
- Belnoue, E., F. T. Costa, T. Frankenberg, A. M. Vigário, T. Voza, N. Leroy, M. M. Rodrigues, I. Landau, G. Snounou, and L. Rénia. 2004. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol. 1722487-2495. - PubMed
-
- Berenzon, D., R. J. Schwenk, L. Letellier, M. Guebre-Xabier, J. Williams, and U. Krzych. 2003. Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells. J. Immunol. 1712024-2034. - PubMed
-
- Boyd, M., and S. F. Kitchen. 1937. Recurring clinical activity in infections with the McCoy strain of Plasmodium vivax. Am. J. Trop. Med. 17833-843.
-
- Boyd, M., and S. F. Kitchen. 1937. Simultaneous inoculation with Plasmodium vivax and Plasmodium falciparum. Am. J. Trop. Med. 17855-861.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources